These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 20167145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J, Mansfield LE, Uryniak T, O'Brien CD.
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma.
    Corren J, Korenblat PE, Miller CJ, O'Brien CD, Mezzanotte WS.
    Clin Ther; 2007 May; 29(5):823-843. PubMed ID: 17697902
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M, Rosenwasser LJ, Martin P, O'Brien CD, O'Dowd L.
    Drugs; 2006 May; 66(17):2235-54. PubMed ID: 17137405
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapeutic equivalence of budesonide/formoterol delivered via breath-actuated inhaler vs pMDI.
    Murphy KR, Dhand R, Trudo F, Uryniak T, Aggarwal A, Eckerwall G.
    Respir Med; 2015 Feb; 109(2):170-9. PubMed ID: 25596138
    [Abstract] [Full Text] [Related]

  • 9. The effect of budesonide/formoterol pressurized metered-dose inhaler on predefined criteria for worsening asthma in four different patient populations with asthma.
    Murphy KR, Uryniak T, Martin UJ, Zangrilli J.
    Drugs R D; 2012 Mar 01; 12(1):9-14. PubMed ID: 22329608
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial.
    Tashkin DP, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M.
    Drugs; 2008 Mar 01; 68(14):1975-2000. PubMed ID: 18778120
    [Abstract] [Full Text] [Related]

  • 12. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 01; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 13. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P, Creemers JP, Vondra V, Black PN, Lindqvist A, Nihlen U, Vogelmeier C.
    Respir Med; 2006 Dec 01; 100(12):2151-9. PubMed ID: 16701989
    [Abstract] [Full Text] [Related]

  • 14. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma.
    Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O'Dowd L.
    Curr Med Res Opin; 2008 Mar 01; 24(3):879-94. PubMed ID: 18267051
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6-<12 years).
    Pearlman DS, Eckerwall G, McLaren J, Lamarca R, Puu M, Gilbert I, Jorup C, Sandin K, Lanz MJ.
    Ann Allergy Asthma Immunol; 2017 Apr 01; 118(4):489-499.e1. PubMed ID: 28256307
    [Abstract] [Full Text] [Related]

  • 16. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE, Noonan MJ.
    J Asthma; 2010 May 01; 47(4):447-59. PubMed ID: 20528601
    [Abstract] [Full Text] [Related]

  • 17. Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: a randomized controlled trial.
    Brown RW, O'Brien CD, Martin UJ, Uryniak T, Lampl KL.
    J Allergy Clin Immunol; 2012 Aug 01; 130(2):362-7.e9. PubMed ID: 22541245
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
    Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE.
    Drugs; 2009 Aug 01; 69(5):549-65. PubMed ID: 19368417
    [Abstract] [Full Text] [Related]

  • 19. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients.
    Peters SP, Prenner BM, Mezzanotte WS, Martin P, O'Brien CD.
    Allergy Asthma Proc; 2008 Aug 01; 29(5):499-516. PubMed ID: 18694544
    [Abstract] [Full Text] [Related]

  • 20. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter.
    Shah S, White M, Uryniak T, O'Brien CD.
    Allergy Asthma Proc; 2010 Aug 01; 31(1):40-8. PubMed ID: 20167144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.